妊娠期肺动脉高压:北美四家三级中心49例病例报告
该回顾性研究分析了2001至2015年北美四家学术机构的49例妊娠合并肺动脉高压患者,发现死亡率为16%(8/49),所有死亡均发生在产后,其中7例为WHO第1组肺动脉高压。严重肺动脉高压患者需要更多先进治疗且早产更常见,作者认为在预后良好的特定患者中可考虑尝试阴道分娩。
要点
- 妊娠合并肺动脉高压死亡率为16%(8/49),所有死亡均发生在产后。
- WHO第1组肺动脉高压死亡率为23%(7/30),严重者死亡率高于轻度者。
- 严重肺动脉高压患者需要更多先进治疗(19/26 vs 7/22)且早产更常见(19/23 vs 8/17)。
核心结论
- 在这大样本妊娠合并肺动脉高压系列中,尽管采用先进治疗,死亡率仍高。
- 孕产妇死亡仅见于WHO第1组肺动脉高压,且可能与严重肺动脉高压相关。
- 在预后良好的特定患者中,作者认为可考虑尝试阴道分娩。
研究设计与样本
- 回顾性病历回顾研究,纳入北美四家学术机构2001至2015年妊娠合并肺动脉高压的49例患者。
主要发现
- 总死亡率为16%(8/49),所有死亡均发生在产后。
- WHO第1组肺动脉高压死亡率为23%(7/30)。
- 在已知分娩方式且活产的41例中,严重肺动脉高压死亡4/22,轻度死亡1/19;剖宫产死亡4/22,阴道分娩死亡1/19。
- 严重肺动脉高压患者需要更多先进治疗(19/26 vs 7/22),早产更常见(19/23 vs 8/17)。
- 椎管内麻醉用于22例剖宫产中的20例和19例阴道分娩中的17例,无麻醉相关不良事件。
关键数值与推荐
- 轻度肺动脉高压定义为平均肺动脉压25-49 mm Hg。
- 严重肺动脉高压定义为平均肺动脉压50 mm Hg或以上,或收缩期肺动脉压70 mm Hg或以上。
- 按2013年世界卫生组织(WHO)肺动脉高压分类分为1-5组。
临床怎么用
- 在预后良好的特定患者中,作者认为可考虑尝试阴道分娩。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify whether pregnancy outcomes vary by etiology and severity of pulmonary hypertension and whether contemporary therapies influence outcomes. METHODS: A retrospective review of medical records at four academic institutions was conducted to identify pregnant women with pulmonary hypertension (2001-2015). International Classification of Diseases, 9th Revision codes for pulmonary hypertension and pregnancy were used to identify potential participants. Medical records were abstracted for demographics, management, and outcomes. Women were classified according to the 2013 World Health Organization (WHO) pulmonary hypertension classification groups 1-5. Mild pulmonary hypertension was defined as a mean pulmonary artery pressure 25-49 mm Hg and severe pulmonary hypertension as mean pulmonary artery pressure 50 mm Hg or greater or systolic pulmonary artery pressure 70 mm Hg or greater. Descriptive statistics were used to compare outcomes. RESULTS: Forty-nine women were identified. Mortality rate was 16% (n=8/49); all deaths occurred postpartum, and seven of eight deaths occurred in women with WHO group 1 pulmonary hypertension (mortality rate 23%, n=7/30). Of the women who had documented live births with known mode of delivery (n=41), mortality was 4 of 22 among women with severe pulmonary hypertension and 1 of 19 among women with mild pulmonary hypertension. Mortality among women who delivered by cesarean was 4 of 22 and was 1 of 19 among women who delivered vaginally. Neuraxial anesthesia was performed in 20 of 22 cesarean and 17 of 19 vaginal deliveries with no anesthesia-related adverse events. Women with severe pulmonary hypertension needed more advanced therapies such as inotropes, pulmonary vasodilators, and extracorporeal membrane oxygenation than did women with mild pulmonary hypertension, 19 of 26 compared with 7 of 22. Preterm delivery was more common in women with severe compared with mild pulmonary hypertension, 19 of 23 compared with 8 of 17. There was one 25-week intrauterine fetal demise, but no neonatal deaths. CONCLUSION: In this large series of pulmonary hypertension in pregnancy, mortality remained high despite advanced therapies. Maternal mortality was specific to WHO group 1 pulmonary hypertension and possibly associated with severe pulmonary hypertension. In selected patients with a favorable prognosis for vaginal birth, a trial of labor can be considered.
引用
- Meng ML, Landau R, Viktorsdottir O, et al. Pulmonary Hypertension in Pregnancy: A Report of 49 Cases at Four Tertiary North American Sites. Obstet Gynecol. 2017. PMID: 28178055. doi:10.1097/AOG.0000000000001896
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。